Cargando…

Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking

Danshen (Salvia miltiorrhiza Bunge), a natural powerful drug for various conditions treatment, has traditionally been used in Asian countries for centuries as anticancer agent, anti-inflammatory agent, and antioxidant. More recently, it is explored in combination with other herbs for skeletal diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jie, Ma, Xiaoran, Liu, Cun, Li, Huayao, Zhuang, Jing, Gao, Chundi, Zhou, Chao, Liu, Lijuan, Wang, Kejia, Sun, Changgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304517/ https://www.ncbi.nlm.nih.gov/pubmed/30622613 http://dx.doi.org/10.1155/2018/8363295

Ejemplares similares

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas
por: Liu, Cun, et al.
Publicado: (2019)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
por: Zhang, Yubao, et al.
Publicado: (2021)

Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy
por: Li, Huayao, et al.
Publicado: (2018)

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method
por: Liu, Cun, et al.
Publicado: (2019)

A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology
por: Zhou, Chao, et al.
Publicado: (2018)

Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer
por: Gao, Chundi, et al.
Publicado: (2022)

The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
por: Gao, Chundi, et al.
Publicado: (2018)

Identification of key candidate genes and miRNA-mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis
por: Gao, Chundi, et al.
Publicado: (2019)

Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database
por: Gao, Chundi, et al.
Publicado: (2021)

Determination of Genetic and Epigenetic Modifications-Related Prognostic Biomarkers of Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
por: Zhang, Xiaolu, et al.
Publicado: (2021)

Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a “drug target prediction-gene microarray analysis-protein network construction” strategy
por: Li, Huayao, et al.
Publicado: (2019)

SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database
por: Gao, Chundi, et al.
Publicado: (2019)

Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis
por: Li, Huayao, et al.
Publicado: (2019)

Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
por: Gao, Chundi, et al.
Publicado: (2022)

Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
por: Gao, Chundi, et al.
Publicado: (2020)

7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis
por: Li, Huayao, et al.
Publicado: (2019)

Tumor Mutation Burden and Immune Invasion Characteristics in Triple Negative Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021)

Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms
por: Li, Huayao, et al.
Publicado: (2021)

Using network pharmacology and molecular docking to explore the underlying anti-inflammatory mechanism of Wuyao-Danshen to treat endometriosis
por: Zhu, Jie, et al.
Publicado: (2022)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
por: Shen, Xuetong, et al.
Publicado: (2023)

Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method
por: Ma, Xiaoran, et al.
Publicado: (2020)

Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis
por: Liu, Cun, et al.
Publicado: (2018)

Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer
por: Liu, Cun, et al.
Publicado: (2022)

Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis
por: Li, Jie, et al.
Publicado: (2019)

Investigating the molecular mechanism of Compound Danshen Dropping Pills for the treatment of epilepsy by utilizing network pharmacology and molecular docking technology
por: Huang, Dan, et al.
Publicado: (2022)

6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data
por: Zhang, Xiaoming, et al.
Publicado: (2021)

Integrative transcriptome data mining for identification of core lncRNAs in breast cancer
por: Zhang, Xiaoming, et al.
Publicado: (2019)

Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
por: Cao, Minling, et al.
Publicado: (2022)

Mechanisms and Molecular Targets of Compound Danshen Dropping Pill for Heart Disease Caused by High Altitude Based on Network Pharmacology and Molecular Docking
por: Yan, Jiayi, et al.
Publicado: (2021)

Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity
por: Xu, Xiaowei, et al.
Publicado: (2022)

From tumor mutational burden to characteristic targets analysis: Identifying the predictive biomarkers and natural product interventions in cancer management
por: Liu, Cun, et al.
Publicado: (2022)

Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction
por: Lin, Tsai-Hui, et al.
Publicado: (2010)

Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis
por: Yang, Kailin, et al.
Publicado: (2020)

Retracted: Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi‐target pharmacology of fenugreek against diabetes
por: Luo, Wenfeng, et al.
Publicado: (2023)

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment
por: Liu, Jingyang, et al.
Publicado: (2022)

Epigenetic modifications: Critical participants of the PD-L1 regulatory mechanism in solid tumors (Review)
por: Ma, Xiaoran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ji539bj7hougc36tqqo2cfmvq7